Dolby Laboratories Inc. logo

Dolby Laboratories Inc.

DLB | NYSE
Chart Builder DCF Calculator
$57.33
-$0.32 (-0.56%)
At close: Sep 21, 2026, 4:00 PM ET
$57.33
$0 (0.00%)
After-hours: Sep 21, 2026, 5:24 PM ET
-0.56%

Rating

Updated: Sep 1, 2026
49.1
Fundamentals Average
Market Sentiment Neutral
Moat Narrow

Key Statistics

Market Data

Market Cap $5.45B
1D Range
56.86 58.38
52W Range
48.26 73.01

Valuation (TTM)

PE 24.40
PB 2.11
EV/EBITDA 14.05

Valuation (NTM)

Forward PE 12.30
Forward PEG 4.05
Price Target $90.33
Loading financial charts...

Profile

Dolby Laboratories, Inc. develops pioneering audio and visual technologies designed to enhance entertainment and communication experiences across a broad spectrum of platforms. These include cinematic...

Sector Technology
Employees 2,051
IPO Date Feb 16, 2005
Fiscal Year October - September

Latest News

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan

6 days ago · prnewswire.com

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026

12 days ago · prnewswire.com

Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?

21 days ago · zacks.com

Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?
3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

22 days ago · zacks.com

3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds
Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?

22 days ago · zacks.com

Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?
Dolby Laboratories Announces Leadership Transition

26 days ago · prnewswire.com

Dolby Laboratories Announces Leadership Transition
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level

1 month ago · gurufocus.com

Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock

1 month ago · zacks.com

Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

2 months ago · globenewswire.com

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?

2 months ago · zacks.com

Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?

Earnings

Next Earnings
Nov 17, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$85
Upside
+48.26%
Buy (2)
Hold (0)
Sell (0)
Analyst Details

© 2026 bestshares.com. All rights reserved.